Michallet, A., Aktan, M., Hiddemann, W., Ilhan, O., Johansson, P., Laribi, K., . . . Leblond, V. (2018). Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: Primary analysis of the randomized, open-label MABLE study. Ferrata Storti Foundation.
Čikaški stil citiranja (17. izdanje)Michallet, Anne-Sophie, et al. Rituximab Plus Bendamustine or Chlorambucil for Chronic Lymphocytic Leukemia: Primary Analysis of the Randomized, Open-label MABLE Study. Ferrata Storti Foundation, 2018.
MLA način citiranja (9. izdanje)Michallet, Anne-Sophie, et al. Rituximab Plus Bendamustine or Chlorambucil for Chronic Lymphocytic Leukemia: Primary Analysis of the Randomized, Open-label MABLE Study. Ferrata Storti Foundation, 2018.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.